Daniel Habermehl
Papers
2
Total Citations
168
H-Index
2
About
Daniel Habermehl is a leading figure in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) for metastatic disease and precision particle therapy. His most impactful contribution is the landmark SBRT database initiative of the German Society for Radiation Oncology (DEGRO), which analyzed patterns of care and outcomes for 474 patients with 623 liver oligometastases. This study, cited over 150 times, established critical factors influencing local tumor control and overall survival, helping to standardize SBRT for liver metastases across Germany. Dr. Habermehl has also advanced the technical accuracy of particle radiation therapy, investigating inter- and intrafraction positioning errors with commercial thermoplastic masks for head-and-neck, brain, and skull base tumors. His work on image-guided particle therapy has directly improved treatment precision and patient safety. Through these contributions, he has shaped clinical guidelines for SBRT in oligometastatic disease and enhanced the reliability of high-precision radiotherapy, making him a key researcher in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2